论文部分内容阅读
目的探讨2型糖尿病的有效治疗方法 ,观察优泌林70/30R治疗2型糖尿病的临床疗效及安全性。方法回顾性分析本社区卫生服务中心2011年1月~2013年1月间收治的43例确诊为2型糖尿病患者的临床资料,所有患者均给予优泌林70/30R治疗,观察患者治疗前后的血糖水平变化情况,评价临床疗效及安全性。结果本组43例2型糖尿病患者经优泌林70/30R治疗后,空腹血糖、餐后2 h血糖以及糖化血红蛋白水平均较治疗前有显著改善,差异有统计学意义(P<0.05),治疗后患者的血糖水平均控制在了理想范围。治疗过程中仅2例患者出现低血糖,低血糖发生率为4.7%。结论采用优泌林70/30R治疗2型糖尿病能够有效控制患者的血糖水平,且低血糖的发生率较少,是一种理想的治疗方式,具有一定的临床应用价值。
Objective To investigate the effective treatment of type 2 diabetes mellitus and to observe the clinical efficacy and safety of Urogelin 70 / 30R in the treatment of type 2 diabetes mellitus. Methods Retrospective analysis of the clinical data of 43 patients diagnosed as type 2 diabetes admitted to our community health service center between January 2011 and January 2013. All patients were treated with Euclidean 70 / 30R, and the patients’ Changes in blood glucose levels, evaluation of clinical efficacy and safety. Results The fasting blood glucose, 2 h postprandial blood glucose and glycosylated hemoglobin were significantly improved in 43 patients with type 2 diabetes mellitus after treatment with Euclidean 70 / 30R compared with before treatment (P <0.05) After treatment, the patient’s blood glucose levels are controlled in the ideal range. Hypoglycemia was observed in only 2 patients during treatment, with a hypoglycemic rate of 4.7%. Conclusion The treatment of type 2 diabetes with Euclidean 70 / 30R can effectively control the blood glucose level of the patients with low incidence of hypoglycemia, which is an ideal treatment and has certain clinical value.